Jagsonpal Pharmaceuticals Share Price

NSE
JAGSNPHARM •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or Open Demat Account for live prices.
Start SIP in Jagsonpal Pharmaceuticals
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
37.52% Fall from 52W High
-22.7
Dividend yield 1yr %
Above industry Median
1

Jagsonpal Pharmaceuticals shareholding Pattern

Promoter
67.8%
Foreign Institutions
2.1%
Public
30.1%
Promoter
68%
Foreign Institutions
2.3%
Mutual Funds
0.1%
Domestic Institutions
0.1%
Public
29.6%
Promoter
68%
Foreign Institutions
1.1%
Domestic Institutions
0.8%
Public
30%
Promoter
68.1%
Foreign Institutions
0.7%
Domestic Institutions
0.9%
Public
30.3%
Promoter
68.5%
Foreign Institutions
0.5%
Domestic Institutions
0.9%
Public
30.2%
Promoter
68.7%
Foreign Institutions
0.4%
Domestic Institutions
0.8%
Public
30.1%

Jagsonpal Pharmaceuticals Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
2
Bearish Moving Averages
14
5Day EMA
209.40
10Day EMA
211.70
12Day EMA
212.70
20Day EMA
216.80
26Day EMA
219.60
50Day EMA
226.30
100Day EMA
223.10
200Day EMA
204.60
5Day SMA
211.20
10Day SMA
210.70
20Day SMA
214.70
30Day SMA
226.80
50Day SMA
228.80
100Day SMA
237.80
150Day SMA
213.80
200Day SMA
195.20
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
29375 Rs
76389 Rs
Week Rs
34861 Rs
82003 Rs
Month Rs
63650 Rs
231693 Rs
Resistance & Support
206.77
Pivot
Resistance
First Resistance
210.38
Second Resistance
215.80
Third Resistance
219.41
Support
First Support
201.35
Second support
197.74
Third Support
192.32
Relative Strength Index
40.77
Money Flow Index
43.86
MACD
-6.93
MACD Signal
-7
Average True Range
13.75
Average Directional Index
23.02
Rate of Change (21)
-7.06
Rate of Change (125)
25.70

Jagsonpal Pharmaceuticals Company background

Founded in: 1978
Managing director: Manish Gupta
Promoted by Rajpal Singh Kochhar in August, 1978, Jagsonpal Pharmaceuticals Limited is engaged in the manufacture and marketing bulk drugs and pharmaceuticals at its plant at Faridabad in Haryana. The Company has adopted the strategy of clubbing all its products in seven groups for effective marketing and reducing costs. Simultaneously, it has geared up to set up an ultra modern multipurpose basic drugs and formulation plant through its subsidiary, Jagsonpal Exports India Pvt Ltd.The company has a strategic alliance with Fidia Spa, Italy and B Spofola, Czechoslovakia to manufacture sophisticated drugs in India. It has tied up with another Israelbased company, Makhteshim Chemical Works, for acquiring the marketing rights of an antioxidant product. In 1994, the company has also promoted Aresco Financial Services, a new financial company.The Companys RD activities have resulted in manufacturing process upgradation, improving packaging, and cost containment. Its RD activities are geared towards development of new product technologies which can be commercialised in future.It has tied up with Lycored Natural Products Industries (LNP) of Israel, to launch a completely natural Lycopene bioactive product, Lycored, in India and SouthEast Asia.In the fiscal 2001, the companys sales grew by 15% to Rs 136.52 crore and the profit at the net level was up 8% to Rs 10.15 crore. This was achieved against heavy odds, such as, sluggish market trends, lower growth rate of the industry and severe competition from drug majors. However the company has introduced various measures to counter the above factors so as to achieve continued growth and opportunity.The new manufacturing facility at Pantnagar, Uttarakhand started production in April 2009. The Company launched two brands, Divatrone and ProRetro in the market segment, Dydrogesterone, which was earlier dominated by a global pharma Company in August, 2021.On June 27, 2022, Infinity Holdings, an Indiafocused investment group acquired control over the Company consequent to acquisition of 43.73% of equity capital and became Promoters of the Company. The Company identified several products as part of new launches such as Indocap Gel, Lycored Plus, MemUp, Queezy ER to enhance healthcare professionals confidence and improve patient outcomes in 202324. It acquired the India and Bhutan business of Yash Pharma in May, 2024.
Read More

Jagsonpal Pharmaceuticals FAQs

Jagsonpal Pharmaceuticals share price is ₹204.96 in NSE and ₹204.6 in BSE as on 12/3/2025.

Jagsonpal Pharmaceuticals share price in the past 1-year return was 78.56. The Jagsonpal Pharmaceuticals share hit a 1-year low of Rs. 109.44 and a 1-year high of Rs. 328.04.

The market cap of Jagsonpal Pharmaceuticals is Rs. 1360.67 Cr. as of 12/3/2025.

The PE ratios of Jagsonpal Pharmaceuticals is 37.27 as of 12/3/2025.

The PB ratios of Jagsonpal Pharmaceuticals is 6.88 as of 12/3/2025

You can easily buy Jagsonpal Pharmaceuticals shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Please be aware that Jagsonpal Pharmaceuticals stock prices are subject to continuous fluctuations due to various factors.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -